Literature DB >> 17728237

Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients.

Suwanna Noppornpanth1, Saskia L Smits, Truong Xuan Lien, Yong Poovorawan, Albert D M E Osterhaus, Bart L Haagmans.   

Abstract

Hepatitis C virus (HCV) has a linear positive-stranded RNA genome of approximately 9,600 nucleotides in length and displays a high level of sequence diversity caused by high mutation rates and recombination. However, when we performed long distance reverse transcription-PCRs on HCV RNA isolated from serum of chronic HCV patients, not only full-length HCV genomes but also HCV RNAs which varied in size from 7,600 to 8,346 nucleotides and contained large in-frame deletions between E1 and NS2 were amplified. Carefully designed control experiments indicated that these deletion mutants are a bona fide natural RNA species, most likely packaged in virions. Moreover, deletion mutants were detected in sera of patients infected with different HCV genotypes. We observed that 7/37 (18.9%) of genotype 1, 5/43 (11.6%) of genotype 3, and 4/13 (30.7%) of genotype 6 samples contained HCV deletion mutant genomes. These observations further exemplify HCV's huge genetic diversity and warrant studies to explore their biological relevance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728237      PMCID: PMC2168980          DOI: 10.1128/JVI.01059-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

Review 2.  The origins of defective interfering particles of the negative-strand RNA viruses.

Authors:  R A Lazzarini; J D Keene; M Schubert
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

3.  Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication.

Authors:  Peter Friebe; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Identification and stability of a 30-kDa nonstructural protein encoded by mRNA 2 of mouse hepatitis virus in infected cells.

Authors:  P J Bredenbeek; A F Noten; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

5.  Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection.

Authors:  A Iwai; H Marusawa; Y Takada; H Egawa; K Ikeda; M Nabeshima; S Uemoto; T Chiba
Journal:  J Viral Hepat       Date:  2006-08       Impact factor: 3.728

6.  Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.

Authors:  R A Fouchier; T M Bestebroer; S Herfst; L Van Der Kemp; G F Rimmelzwaan; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 7.  Hepatitis C virus genotyping: clinical implications and methods.

Authors:  F S Nolte
Journal:  Mol Diagn       Date:  2001-12

8.  Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures.

Authors:  M A Brinton
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

9.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.

Authors:  Chien-Te K Tseng; Gary R Klimpel
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  30 in total

1.  Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events.

Authors:  Konstantina Katsarou; Alexandros Alpha Lavdas; Panagiota Tsitoura; Elisavet Serti; Panagiotis Markoulatos; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient non-responding to PEG-interferon-alpha/ribavirin therapy.

Authors:  D Kmieciak; P Migdalski; J Juszczyk; P P Jagodziński; W H Trzeciak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 3.267

3.  Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

Authors:  Isabel Gallego; María Eugenia Soria; Carlos García-Crespo; Qian Chen; Patricia Martínez-Barragán; Soumaya Khalfaoui; Brenda Martínez-González; Irene Sanchez-Martin; Inés Palacios-Blanco; Ana Isabel de Ávila; Damir García-Cehic; Juan Ignacio Esteban; Jordi Gómez; Carlos Briones; Josep Gregori; Josep Quer; Celia Perales; Esteban Domingo
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  High multiplicity infection following transplantation of hepatitis C virus-positive organs.

Authors:  Muhammad N Zahid; Shuyi Wang; Gerald H Learn; Peter L Abt; Emily A Blumberg; Peter P Reese; David S Goldberg; George M Shaw; Katharine J Bar
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

5.  Genetic Analysis of Serum-Derived Defective Hepatitis C Virus Genomes Revealed Novel Viral cis Elements for Virus Replication and Assembly.

Authors:  Qingchao Li; Yimin Tong; Yongfen Xu; Junqi Niu; Jin Zhong
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 6.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

7.  Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.

Authors:  Elisavet Serti; Polyxeni P Doumba; George Thyphronitis; Panagiota Tsitoura; Konstantina Katsarou; Pelagia Foka; Manousos M Konstandoulakis; John Koskinas; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

8.  Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.

Authors:  Kenneth A Stapleford; Brett D Lindenbach
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

9.  Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo.

Authors:  José M Cuevas; Fernando González-Candelas; Andrés Moya; Rafael Sanjuán
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

10.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.